Dimethyl Fumarate Induces Metabolic Crisie to Suppress Pancreatic Carcinoma
Dimethyl fumarate (DMF) is an approved drug used in the treatment of multiple sclerosis (MS) and psoriasis therapy. Multiple studies have demonstrated other pharmacological activities of DMF such as an anti-cancer agent. In particular, studies have shown that DMF can modulate the NRF2/HO1/NQO1 antio...
Saved in:
Main Authors: | Kaiyuan Chen (Author), Shanshan Wu (Author), Sisi Ye (Author), Huimin Huang (Author), Yi Zhou (Author), Hongfei Zhou (Author), Shijia Wu (Author), Yefan Mao (Author), Fugen Shangguan (Author), Linhua Lan (Author), Bicheng Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-Repurposing Strategy for Dimethyl Fumarate
by: Salvatore Giunta, et al.
Published: (2023) -
Short-term exposure to dimethyl fumarate (DMF) inhibits LPS-induced IκBζ expression in macrophages
by: Yong Zhang, et al.
Published: (2023) -
Dimethyl fumarate for treating Papillon-Lefèvre syndrome
by: Abdullah Al-Omair, MD, et al.
Published: (2023) -
Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate
by: Shiri Li, et al.
Published: (2021) -
Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro
by: Takehiro Kawashiri, et al.
Published: (2018)